Handheld IVCM Vivascope 3000 (Caliber/Mavig) anesthesic eyedrop : oxybuprocaïne Thea 1,6 mg/0,4 ml
Deviceused anesthesic eyedrop : oxybuprocaïne Thea 1,6 mg/0,4 ml
NCT Number: NCT02386774
In vivo confocal microscopy (IVCM) used in tertiary care ophthalmology centers is performed with two reflectance microscopes attached on a mounting with limited movement along the XYZ axes. Consequently, ocular diseases in the central area have been described (mostly cornea and adjacent conjunctiva). Two dermatology IVCM (an handheld small IVCM and a multifluorescent one) present significant innovations that the investigators want to assess in ophthalmology for the diagnosis of conjunctiva, cornea, eyelid and lachrymal tract diseases. The handheld IVCM have unlimited degrees of freedom and a small diameter objective. It could dramatically increase the area accessible to IVCM (whole conjunctiva, eyelids, proximal lachrymal tract) (part 1 of the present study). The fluorescent IVCM allows the use of a wide range of fluorescent markers liable to increase the specificity of the diagnosis by revealing staining patterns corresponding to a specific disease and not to others (part 2 of the study)
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Chu de Saint Etienne, Saint-Etienne, Dermatology, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
used anesthesic eyedrop : oxybuprocaïne Thea 1,6 mg/0,4 ml
used for Multifluorescence IVCM
realization of the microangiography with intravenous injection of fluoresceine and indocyanine green.
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
using a scale to 3 levels (2 : optic diagnosis ; 1 : presence of artifacts but possible optic diagnosis ; 0 :impossible optic diagnosis)
Time frame: 1 year
(in the particular case of tumors requiring surgery)
Time frame: 1 year
Time frame: 1 year
characteristics of the conjunctival vessels in normal and diabetic patients
Centre Hospitalier Universitaire de Saint Etienne
Other
Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa : Study of a Handheld in Vivo Confocal Microscope and of a Fluorescent in Vivo Confocal Microscope
Acronym: INNOV-EYE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03706443
Conjunctival Diseases, Conjunctivitis
Columbus, Ohio, United States
View Trial DetailsNCT00008541
Blepharitis, Conjunctival Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06101017
Corneal Disease, Corneal Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT03990506
Corneal Biomechanics, Corneal Crosslinking
Umeå, Sweden
View Trial Details